Use of bisphosphonates in multiple myeloma: IMWG response to Mayo Clinic consensus statement - Reply

被引：1

作者：

Lacy, Martha Q. ^{[1
]}

Rajkumar, S. Vincent ^{[1
]}

机构：

[1] Mayo Clin, Coll Med, Myeloma Grp, Rochester, MN 55905 USA

来源：

MAYO CLINIC PROCEEDINGS | 2007年 / 82卷 / 04期

关键词：

D O I：

10.4065/82.4.517

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：517 / 518

页数：2

共 2 条

[1] Maintenance, therapy with thalidomide improves survival in patients with multiple myeloma [J].

Attal, Michel ;

Harousseau, Jean-Luc ;

Leyvraz, Serge ;

Doyen, Chantal ;

Hulin, Cyrille ;

Benboubker, Lofti ;

Agha, Ibrahim Yakoub ;

Bourhis, Jean-Henri ;

Garderet, Laurent ;

Pegourie, Brigitte ;

Dumontet, Charles ;

Renaud, Marc ;

Voillat, Laurent ;

Berthou, Christian ;

Marit, Gerald ;

Monconduit, Mathieu ;

Caillot, Denis ;

Grobois, Bernard ;

Avet-Loiseau, Herve ;

Moreau, Philippe ;

Facon, Thierry .

BLOOD, 2006, 108 (10) :3289-3294

[2] Incidence, risk factors and management of osteonecrosis of the jaw in patients with multiple myeloma: a single-centre experience in 303 patients [J].

Zervas, Kostas ;

Verrou, Evgenia ;

Teleioudis, Zisis ;

Vahtsevanos, Konstantinos ;

Banti, Anastasia ;

Mihou, Dimitra ;

Krikelis, Dimitris ;

Terpos, Evangelos .

BRITISH JOURNAL OF HAEMATOLOGY, 2006, 134 (06) :620-623

← 1 →